These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 311086)

  • 1. Influence of high ionic strength buffers on factor VIII/von Willebrand factor from different species.
    Lavergne JM; Meyer D; Jenkins CS; Obert B; Larrieu MJ
    Thromb Res; 1978 Sep; 13(3):409-18. PubMed ID: 311086
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-von Willebrand's disease.
    Hoyer LW
    N Engl J Med; 1982 Feb; 306(6):360-2. PubMed ID: 6798443
    [No Abstract]   [Full Text] [Related]  

  • 6. On von Willebrand's disease (vWd).
    Firkin BG; Howard MA
    Br J Haematol; 1976 Feb; 32(2):151-8. PubMed ID: 1082345
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 8. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of von Willebrand factor in blood stored at 4 degrees C.
    Hondow JA; Russell WJ; Tunbridge LJ; Lloyd JV
    Thromb Res; 1982 Jul; 27(2):125-30. PubMed ID: 6814001
    [No Abstract]   [Full Text] [Related]  

  • 10. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of factor VIII related antigen as a means of demonstrating extramedullary haemopoiesis.
    Crocker J; Smith PJ
    J Clin Pathol; 1985 Mar; 38(3):355. PubMed ID: 3919067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Von Willebrand disease--a variation with an aberrant multimeric structure].
    Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
    Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 18. The ultrastructural localization of von Willebrand factor in endothelial cells.
    Warhol MJ; Sweet JM
    Am J Pathol; 1984 Nov; 117(2):310-5. PubMed ID: 6093546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
    Batlle J; López Fernández MF; López Berges C; López Borrasca A
    Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
    Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
    Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.